B+
Bull case
25%
Probability
Target price
$235.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
NUTX
Nutex HealthBNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$180.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$125.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-08
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+52.5
Score
AI commentary
The post-print tone is constructive but mixed: MarketBeat's Q2 earnings page recorded a $162.07 close on August 7, up 6.67%, while reported revenue declined. The same page displayed consensus EPS and expected-revenue figures but left actual and beat/miss fields unpopulated, so no reliable earnings-surprise comparison or analyst revision signal is available. The company-source results improve the near-term setup, but limited forward visibility supports a monitoring stance.
RankAlpha Sentiment Codex - 2026-08-08
Open post-earnings memoEvidence flagged
later post-earnings follow-up lacks concrete company-source and analyst/market reaction evidence
Impact
tentative
Confidence
-
AI events
2026-08-06catalystQ2 profitability and cash-flow inflectionHigh impact
Nutex reported Q2 net income attributable to the company of $65.8 million, diluted EPS of $9.38, adjusted EBITDA of $90.0 million, operating cash flow of $34.2 million, and hospital visits up 9.6% year over year. Revenue declined 13.6%, partly reflecting prior-year IDR collection effects [#SEC-8K-2026-08-06]. MarketBeat's Q2 earnings page recorded a $162.07 close on August 7, up 6.67%.
2026-11-06eventProspective IDR-related cost reliefHigh impact
The HaloMD amendment and lower CMS administrative fee reduced Q2 contract-services expense by $52.3 million; management expects normalized historical contract-services expenses to decline approximately 25%–30% prospectively, subject to regulatory and execution risk [#SEC-8K-2026-08-06].
2027-08-08catalystThree planned hospital openingsHigh impact
Management expects three new hospitals to open during the second half of 2026, supporting longer-term capacity and volume growth, although opening timing and ramp execution remain uncertain [#SEC-8K-2026-08-06].
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-08 • Updated nightlySource: Internal modelMethodology